Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
Protocol approach: frozen shoulder (adhesive capsulitis) Goal: Reduce capsular fibrosis, restore range of motion, manage pain Peptide approach: BPC-157: 300 to 500 mcg daily for anti-inflammatory and tissue healing properties TB-500: 500 to 750 mcg twice weekly for systemic anti-inflammatory and tissue remodeling Note on relaxin-2: While the most specifically targeted peptide for this condition, it remains largely in the research phase and is not widely available through standard channels Duration: Twelve to sixteen weeks (frozen shoulder has a prolonged natural course) Critical addition: Aggressive physical therapy within pain tolerance
Laboratories produce every batch of BPC-157 / TB-500 Blend Capsules under strict quality standards
10.1172/jci.insight.90777 JCI Insight 55 LiddellJ
Call us at 323-875-8203 now and ask your questions
A longevity label is not clinical evidence Describing a product as a longevity peptide, telomere peptide or pineal bioregulator does not establish that it changes human ageing, healthspan or survival
US$ 20.92
US$ 24.76
US$ 26.10
